Macaldowie, A., Wang, Y. A., Chambers, G. M., & Sullivan, E. A. (2012). Assisted Reproductive Technology in Australia and New Zealand 2010. AIHW National Perinatal Epidemiology and Statistics Unit.
Macaldowie A, Wang YA, Chambers GM, Sullivan EA. Assisted Reproductive Technology in Australia and New Zealand 2010. AIHW National Perinatal Epidemiology and Statistics Unit; 2012.
Macaldowie, A., et al. Assisted Reproductive Technology in Australia and New Zealand 2010. AIHW National Perinatal Epidemiology and Statistics Unit, 2012.
For EndNote, Zotero or Mendeley:
License
Open-access status not yet checked.
RRM Academy Synopsis
18.1% of Australian and New Zealand ART cycles ended in live delivery
The 2010 annual registry report for Australia and New Zealand finds that 18.1% of ART cycles ended in a live delivery. Fertility centers supplied 61,774 started cycles. Clinical pregnancy followed in 23.9% of cycles, and younger women had higher live delivery rates.
Key Findings
The Australian and New Zealand registry recorded 61,774 ART cycles in 2010. Clinical pregnancy followed in 14,752 (23.9%), live delivery in 11,169 (18.1%), and 12,056 babies were liveborn.
Live deliveries per initiated autologous fresh cycle were 29.2% under age 30, 26.8% at 30 to 34, 18.9% at 35 to 39, 6.9% at 40 to 44 and 0.1% from 45.
Multiple deliveries declined from 12% of deliveries in 2006 to 7.9% in 2010, a trend the report links to greater use of single embryo transfer.
Delivery followed 76.4% of 14,733 clinical pregnancies from autologous and recipient embryo transfers, and early pregnancy loss, meaning under 20 weeks gestation and under 400 grams, followed 21.7%.
Almost 18% of babies born after embryo transfer were preterm, against 8.2% in Australia in 2009, and perinatal mortality was 13.5 per 1,000 births, against 9.8 in Australia in 2009.
Interpretation
The report is the sixteenth annual publication of a registry for Australia and New Zealand, and most of its rates are calculated per started cycle. Some women have several cycles, so a rate per cycle differs from a rate per woman. The registry reports on ART and donor sperm insemination treatments. The ART figures describe what followed those cycles and do not estimate what the treatment itself added. Clinicians assign the cause of infertility, and definitions may vary among centers. The authors advise caution with the perinatal mortality figures because of small numbers and potential variability in case reporting, which self-reported birth outcome data compound.
RRM Context
Restorative reproductive medicine identifies the cause of infertility and treats it. The registry defines ART as laboratory handling of eggs, sperm or embryos to establish a pregnancy. Of 60,687 cycles with a woman's own or donor eggs or embryos, 21.7% had male factor alone and 25.2% had unexplained infertility. Restorative clinicians see unexplained infertility as undiagnosed and evaluate both partners. NaProTechnology and the Creighton Model use charted cycles for this.
Our editorial summary of this paper, not the article's abstract.
Key figures
Treatment activity, 2010
Measure
Value
Source
Total ART treatment cycles performed in Australia and New Zealand, 2010
61,774
Summary
ART treatment cycles performed in Australia, 2010
56,489
Summary
ART treatment cycles performed in New Zealand, 2010
5,285
Summary
Year-on-year decrease in Australian ART cycle numbers, 2010 vs previous year
13.4%
Summary
Year-on-year decrease in New Zealand ART cycle numbers, 2010 vs previous year
1%
Summary
Autologous cycles (using a woman's own oocytes or embryos) as a share of all ART treatments, 2010
94.8%
Summary
Cycles using frozen or thawed embryos as a share of all ART cycles, 2010
35.1%
Summary
Autologous ART cycles, 2010
58,574
Treatment overview
Fresh cycles among autologous ART cycles, 2010
36,873 (63%)
Treatment overview
Pregnancy and birth outcomes, 2010
Measure
Value
Source
Clinical pregnancy rate per initiated ART cycle, 2010
23.9%
Summary
Live delivery rate per initiated ART cycle, 2010
18.1%
Summary
Live delivery rate by maternal age, autologous cycles, 2010
Measure
Value
Source
Live delivery rate, autologous fresh cycles, women aged 30-34, 2010
26.8%
Summary, age and outcomes
Live delivery rate, autologous thaw cycles, women aged 30-34, 2010
21.8%
Summary, age and outcomes
Live delivery rate, autologous fresh cycles, women aged over 44, 2010
less than 1%
Summary, age and outcomes
Live delivery rate, autologous thaw cycles, women aged over 44, 2010
8.4%
Summary, age and outcomes
Live delivery rate per initiated cycle, autologous fresh cycles, youngest maternal age band, 2010
29.2
Autologous fresh cycle outcomes by maternal age band
Live delivery rate per initiated cycle, autologous fresh cycles, third-youngest maternal age band, 2010
18.9
Autologous fresh cycle outcomes by maternal age band
Live delivery rate per initiated cycle, autologous fresh cycles, second-oldest maternal age band, 2010
6.9
Autologous fresh cycle outcomes by maternal age band
Live delivery rate per initiated cycle, autologous fresh cycles, oldest maternal age band, 2010
0.1
Autologous fresh cycle outcomes by maternal age band
Live delivery rate per initiated cycle, autologous fresh cycles, average across all maternal age bands, 2010
18.5
Autologous fresh cycle outcomes by maternal age band
Babies born and multiples, 2010
Measure
Value
Source
Liveborn babies from ART treatments, 2010
12,056
Summary
Full-term singleton babies of normal birthweight, share of ART liveborn babies, 2010
74.4%
Summary
Multiple birth delivery rate for ART, 2006 to 2010
12% down to 7.9%
Summary, multiple births
Embryo transfer practice, 2010
Measure
Value
Source
Fresh and thawed embryo transfer cycles, 2010
50,495
Number of embryos transferred
Single embryo transfer (SET) cycles, share of embryo transfer cycles, 2010
69.6%
Number of embryos transferred
Double embryo transfer (DET) cycles, share of embryo transfer cycles, 2010
29.6%
Number of embryos transferred
Live delivery rate, autologous fresh cycles, single embryo transfer, 2010
25%
Table 11
Live delivery rate, autologous fresh cycles, double embryo transfer, 2010
21.4%
Table 11
Trends, 2006 to 2010
Measure
Value
Source
Single embryo transfer cycles, share of embryo transfer cycles, 2006 to 2010
56.9% to almost 70%
Summary, multiple births
Blastocyst embryo transfers, share of embryo transfers, 2006 to 2010
27.1% to 52.1%
Summary, trends in ART procedures
Autologous cycles undertaken by women aged 40 or older, share of autologous cycles, 2006 to 2010
20.6% to 24.3%
Summary, age and parity
Our summary of the report's published figures, each citing its table, figure or section. The full report is at the publisher's link.
A global reference to national IVF registries (HFEA, RTAC, ANZARD, Q-IVF, CDC, DIR, JSOG, CARTR Plus, REDLARA, ESHRE EIM, ICMART) and the codes of practice that govern fertility clinics. What each measures, and what they miss.